Top 3 Australian Growth Stocks With Earnings Growth Up To 65%

Simply Wall St · 1d ago

Higher interest rates are creating a global credit squeeze, and lenders are rewarding borrowers with solid finances and clear growth plans. That puts fast expanding Australian businesses with substantial insider ownership in a brighter spotlight. When founders and executives keep meaningful stakes, their fortunes move with yours. This article walks through three such growth stocks, all filtered for strong insider commitment and positive commentary from both analysts and management.

The three stocks highlighted here offer a compelling starting point if you want exposure to fast growing businesses where insiders are strongly aligned with shareholders. However, if you want the standouts, these 24 high growth high conviction stocks are the most outstanding.

Regis Healthcare (ASX:REG)

Overview: Regis Healthcare runs residential aged care homes, dementia and palliative units, and in home care services across Australia, directly tied to growing aged care demand.

Operations: The group generates about A$1.35b in revenue from Australian residential aged care, home care and retirement living services.

Market Cap: A$1.55b

Regis Healthcare sits squarely in this screener because its growth story is built on more beds, more in home care, and management openly confident about demand. This is a combination the analyst consensus Narrative on Simply Wall St frames through specific capacity and demographic pressures.

"The ongoing and accelerating demographic shift toward a larger aged population in Australia, together with management commentary that thousands of older Australians remain in hospitals awaiting placement and that only 802 net new beds are expected in FY25 against long term forecasts of 200,000 net new beds by 2043, supports scope for Regis Healthcare to sustain high occupancy and grow revenue from services as capacity is added."

What eventually happens to pricing power if one quiet cost pressure keeps grinding away in the background will matter a lot.

That quiet pressure is exactly what the full narrative for Regis Healthcare unpacks in detail, including how Regis Healthcare could respond if costs keep grinding higher while demand accelerates.

ASX:REG Revenue & Expenses Breakdown as at Nov 2026
ASX:REG Revenue & Expenses Breakdown as at Nov 2026

PDI Gold (ASX:PDI)

Overview: PDI Gold explores, develops and operates gold mines in West Africa, with the Kiniéro Gold Mine driving its growth focused story.

Operations: PDI Gold generates about US$156 million from Kiniéro and US$47 million from Nampala, with Kiniéro the larger contributor.

Market Cap: A$4.48b

PDI Gold fits this fast growing, high insider alignment theme because Kiniéro links real gold output to an optimistic build out story. The bearish analyst narrative on Simply Wall St still frames this around execution risk rather than a missing growth engine.

"While Bankan is described as shovel ready, with detailed engineering underway and mechanical equipment largely tendered or procured, the prolonged and unpredictable permit timing in Guinea risks leaving committed capital underutilised and could delay the point at which the project contributes to revenue and earnings."

What happens to the whole growth path if a single timing assumption on project ramp up quietly slips will matter for returns.

That timing risk is only one side of the story, and the full narrative for PDI Gold shows how PDI Gold could still turn permitting friction into an accelerating growth runway.

ASX:PDI Earnings & Revenue Growth as at Nov 2026
ASX:PDI Earnings & Revenue Growth as at Nov 2026

Barrenjoey Group (ASX:BJY)

Overview: Barrenjoey Group manages funds and mandates in global equities and listed infrastructure, with a clear focus on high growth companies.

Operations: The group generates about A$205.7 million from Investment Management Services and A$40.1 million from Partnerships & Investments, with smaller Corporate income.

Market Cap: A$2.56b

Barrenjoey Group fits this screener because its growth focused investment products aim directly at high earnings expansion, and the analyst consensus Narrative on Simply Wall St highlights how that shift toward fee based income could reshape the earnings mix.

"The growth of partnership income to A$25.7 million in the first half of FY26, accounting for 31% of operating profit and supported by contributions from Barrenjoey and Vinva, points to a larger role for capital light fee streams that can affect future margins and profit mix."

What happens if one key assumption about how quickly this newer fee engine offsets past earnings declines quietly proves too optimistic?

If that optimism proves conservative, the full narrative for Barrenjoey Group outlines how Barrenjoey Group’s fee engine could accelerate while older income streams quietly decouple from past constraints.

ASX:BJY Earnings & Revenue Growth as at Nov 2026
ASX:BJY Earnings & Revenue Growth as at Nov 2026

Seeking Fresh Alternatives Before They Fly

New themes are breaking out, momentum is building, and some ideas may still be under the radar for now. Consider exploring opportunities early rather than reacting later.

  • Target reliable income streams by scanning hand picked companies in the 4 dividend fortresses before yield hunters start chasing the same opportunities.
  • Follow developments in AI infrastructure by tracking curated builders behind the 53 AI infrastructure stocks, while this backbone trend may still be under most radars.
  • Evaluate potential commodity exposure by reviewing carefully filtered producers in the 17 top copper producer stocks before any renewed demand affects supply and market attention.